TRPV1 protects the heart against cardiac dysfunction during endotoxemia which is used as a tool to induce or accelerate metabolic syndrome such as hyperlipidemia or obesity (Funk et al., 1993; Clemente-Postigo et al., 2019). This evidence concerns the gene TRPV1 and hyperlipidemia.